-+ 0.00%
-+ 0.00%
-+ 0.00%

BioLineRx initiates Phase 1/2a GLIX1 trial in recurrent glioblastoma; data narrows to H1 2027

Reuters·03/26/2026 11:01:25

Please log in to view news